Português

Authors

  • Armindo D. Tiago Faculdade de Medicina, Universidade Eduardo Mondlane (UEM)
  • Paula Caupers Departamento de Medicina, Hospital Central de Maputo
  • Gilberto Manhiça Faculdade de Medicina, Universidade Eduardo Mondlane (UEM)
  • Amâncio Oliveira Departamento de Medicina, Hospital Central de Maputo, Moçambique
  • João C. Mavimbe Faculdade de Medicina, Universidade Eduardo Mondlane (UEM)

Abstract

The article presents results from a study aimed at determining the weight of Diabetes Mellitus (DM) type 1 among patients with endocrine pathologies and the prevalence of hypertension and sight complications in the Maputo Central Hospital (HCM). The research population consisted of 191 consecutive patients with diabetes mellitus type 1 who were observed during endocrinology consultation at the HCM and the Diabetic Mozambican Association, between March 2006 and March 2011. The statistical data was analyzed using SSPS for Windows 17.0. Results showed that DM type 1 represented about 10% of the DM observed cases at the HCM during the period in question. A relatively high prevalence of hypertension was also observed (9.9% systolic and 8.9% diastolic); different types of sight complications were observed in 14.7% of the patients. The study concluded that the main risk factors that cause HTA are age and the body mass index, while that main risk factors for sight complications are age and the duration of the pathology for diabetes retinopathy (p <.000) and the duration of the pathology for cataract (p <.001). the DM type 1 constitutes the most important endocrine  problem in the specialized consultations at the HCM and it shows a high rate of HTA and sight complications.

References

AZEVEDO, M. e ALLA, S. Diabetes in sub-saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia. Int. J. Diabetes Dev. Ctries, v. 28, n. 4, p. 101-108, Oct., 2008.

BARTELS, M. C. et al. Background diabetic retinopathy in Harare, Zimbabwe. Trop. Doct. v. 29, n. 3, p. 189-190, July 1999.

BERAN, D; YUDKIN, J. S e COURTEN, M. Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care, v. 28, n. 9, p. 2136-2140, 2005.

COOPER, R. S, et al. Prevalence of NIDDM among populations of the African diaspora. Diabetes Care, v. 20, n. 3, p. 343-348, March, 1997.

DALAL, S. et. al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int. J. Epidemiol. v. 28, April, 2011.

DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP. The effect of intensive treatment of diabetes on the Development and progression of long term complications in insulin dependent diabetes mellitus. N. Engl. J. Med, v. 329, p. 977-986, 1993.

ELBAGIR, M. N. et al. Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res. Clin. Pract., v. 30, n. 1, p. 59-67, Oct. 1995.

FRÖHLICH-REITERER, E. E e BRONKESTEIN, M. H. Micro and Macrovascular complications in children and adolescents with type 1 diabetes mellitus. Wien Med Wonhenschr, v. 160, n. 15, p. 414-418, 2010.

GILL, G. V; HUDDLE, K. R e ROLFE, M; Mortality and outcome of insulin-dependent diabetes in Soweto, South Africa. Diabet. Med. v. 12, n. 6, p. 546-550, June 1995.

GOLDBERG, R. B, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation, v. 8, n. 98, p. 2513-2519, Dec., 1998.

GLOVER, S. J. et al. Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan Africa. Br. J. Ophthalmol. April, 2011.

GUEYE, S. M. et. al. Erectile dysfunction in diabetics. Epidemiological profile in Senegal. Prog. Urol., v. 8, n. 3, p. 377-381, June 1998.

GWATKIN, D. R; GUILLOT, M. e HEUVELINE, P. The burden of disease among the global poor. Lancet, v. 14, n. 354, p. 586-589, Aug., 1999.

HALL, V. et al. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications: a systematic review. BMC Public Health, v. 11, p. 564, 2011.

KAIMBO, D. K; KABONGO, B. K e MISSOTTEN, L. Ocular complications in diabetes mellitus in Zaire. Bull. Soc. Belge. Ophtalmol. V. 255, p. 107-713, 1995.

KALK, W. J. et al. Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European and Indian origins. J. Intern. Med. v. 241, n. 1, p. 31-37, Jan. 1997.

KASIAM, L. O. et al. Classification and dramatic epidemic of diabetes mellitus in Kinshasa Hinterland: the prominent role of type 2 diabetes and lifestyle changes among Africans. Niger J. Med. v. 18, n. 3, p. 211-320, July 2009.

KING, H; AUBERT, R. E e HERMAN, W. H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care, v. 21, n. 9, p. 1414-1431, Sept., 1998.

KROLEWSKI, A. S et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N. Engl. J. Med, v. 11, n. 332, p. 1251-1255, May, 1995.

KROLEWSKI, A. S; WARRAM, J. H e FREIRE, M. B. Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs. Endocrinol. Metab. Clin. North. Am., v. 25, n. 2, p. 217-142, June, 1996.

KRONENBERG H. M. Williams Textbook of Endocrinology. 11. ed. New York: Saunders Elsevier, 2007. 1344 p.

LESTER, F. T. Clinical features, complications and mortality in type 1 (insulin-dependent) diabetic patients in Addis Ababa, Ethiopia, 1976-1990. Q. J. Med. v. 83, n. 301, p. 389-399, May 1992.

LEVITT, N. S. et al. Audit of public sector primary diabetes care in Cape Town, South Africa: high prevalence of complications, uncontrolled hyperglycaemia, and hypertension. Diabet. Med. V. 14, n. 12, p. 1073-1077, Dec. 1997.

MOTALA A. A. et al. Microvascular complications in South African patients with long-duration diabetes mellitus. S. Afr. Med. J. V.91, 11, p. 987-992, Nov. 2001.

MOTALA, A. A. et al. Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care, v. 31, n. 9, 2008.

NAMBUYA, A. P. et al. The presentation of newly-diagnosed diabetic patients in Uganda. QJM, v. 89, n. 9, p. 705-711, Sept. 1996.

RAHLENBECK, S. I; GEBRE-YOHANNES, A. Prevalence and epidemiology of micro- and macroalbuminuria in Ethiopian diabetic patients. J. Diabetes Complications, v. 11, n. 6, p. 343-349, Nov. 1997.

ROGLIC, G. et. al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care, v. 28, n. 9, p. 2130-2135, Sept., 2005.

ROLFE, M. Diabetic eye disease in Central Africa. Diabetologia, v. 31, n. 2, p. 88-92, Feb. 1988.

SIDIBE, E. H. Diabetic retinopathy in Dakar and review of African literature: epidemiologic elements. Diabetes Metab, v. 26, n. 4, p. 322-324, Sept. 2000.

SOBNGWI, E. et al. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res. Clin. Pract., v.44, n. 3, p. 191-196, June 1999.

STEICHEN O. Hypertension in black patients. Rev. Prat. v. 20, n. 60, p. 654-659, May 2010.

UK prospective Diabetes study (UKPDS) Group. Intensive blood glucose control with sulphonilureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, v. 352, p. 837-853, 1998.

WAGENKNECHT, L. E, et. al. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care, v. 21, n. 11, p. 1812-1818, Nov., 1998.

WANJOHI, F. W et. al. Nephropathy in patients with recently diagnosed type 2 diabetes mellitus in black Africans. East. Afr. Med. J. v. 79, n. 8, p. 399-404, Aug. 2002.

ERASMUS, R. T. et. al. Diabetic retinopathy in Nigerians: relation to duration of diabetes, type of treatment and degree of control. East. Afr. Med. J., v. 66, n. 4, p. 248-254, April 1989.

WHO. Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J. Hypertens. V. 17, p. 151-183, 1999.

ZIMMET, P; ALBERTI, K. G. e SHAW, J. Global and societal implications of the diabetes epidemic. Nature, v. 13, n. 414, p. 782-787, Dec., 2001.

Published

2020-10-12

How to Cite

Tiago, A. D. ., Caupers, P. . ., Manhiça, G. ., Oliveira, A. ., & Mavimbe, J. C. . (2020). Português. UEM Scientific Journal: Biomedical Sciences and Public Health Series , 1. Retrieved from http://revistacientifica.uem.mz/revista/index.php/cbsp/article/view/3